-
Je něco špatně v tomto záznamu ?
FosA8-producing E. coli ST131: clinical cases in Italy, February 2023
K. Chudejova, MS. Caltagirone, V. Mattioni Marchetti, A. Rezzani, A. Navarra, I. Bitar
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, kazuistiky
NLK
Directory of Open Access Journals
od 1996
Free Medical Journals
od 1995
Freely Accessible Science Journals
od 1995-09-01
PubMed Central
od 2016
Europe PubMed Central
od 2016
Open Access Digital Library
od 1996-01-01
Open Access Digital Library
od 2016-01-01
Medline Complete (EBSCOhost)
od 2010-07-01
ROAD: Directory of Open Access Scholarly Resources
od 1995
- MeSH
- antibakteriální látky * farmakologie terapeutické užití MeSH
- bakteriální léková rezistence MeSH
- beta-laktamasy genetika metabolismus MeSH
- Escherichia coli * izolace a purifikace genetika účinky léků MeSH
- fosfomycin farmakologie terapeutické užití MeSH
- infekce vyvolané Escherichia coli * mikrobiologie epidemiologie MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- multilokusová sekvenční typizace MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- Geografické názvy
- Itálie MeSH
Fosfomycin-resistant FosA8-producing Enterobacterales are uncommon strains with extremely low incidence in Europe, based on only three reports in the literature. We detected FosA8-producing Escherichia coli ST131 in clinical isolates from two patients admitted in February 2023 to a rehabilitation unit in Italy. The occurrence of rare fosA-like genes in the high-risk clone ST131 is of clinical relevance. The dissemination of FosA-producing E. coli, although still at low levels, should be continuously monitored.
Biomedical Center Faculty of Medicine Charles University Pilsen Czechia
Microbiology Unit IRCCS Istituti Clinici Scientifici Maugeri Pavia Italy
Specialization School of Microbiology and Virology University of Pavia Pavia Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014024
- 003
- CZ-PrNML
- 005
- 20240905134120.0
- 007
- ta
- 008
- 240725s2024 sw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2807/1560-7917.ES.2024.29.21.2400276 $2 doi
- 035 __
- $a (PubMed)38785090
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Chudejova, Katerina $u Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia $u Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czechia
- 245 10
- $a FosA8-producing E. coli ST131: clinical cases in Italy, February 2023 / $c K. Chudejova, MS. Caltagirone, V. Mattioni Marchetti, A. Rezzani, A. Navarra, I. Bitar
- 520 9_
- $a Fosfomycin-resistant FosA8-producing Enterobacterales are uncommon strains with extremely low incidence in Europe, based on only three reports in the literature. We detected FosA8-producing Escherichia coli ST131 in clinical isolates from two patients admitted in February 2023 to a rehabilitation unit in Italy. The occurrence of rare fosA-like genes in the high-risk clone ST131 is of clinical relevance. The dissemination of FosA-producing E. coli, although still at low levels, should be continuously monitored.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Escherichia coli $x izolace a purifikace $x genetika $x účinky léků $7 D004926
- 650 12
- $a infekce vyvolané Escherichia coli $x mikrobiologie $x epidemiologie $7 D004927
- 650 12
- $a antibakteriální látky $x farmakologie $x terapeutické užití $7 D000900
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a fosfomycin $x farmakologie $x terapeutické užití $7 D005578
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a beta-laktamasy $x genetika $x metabolismus $7 D001618
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a bakteriální léková rezistence $7 D024881
- 650 _2
- $a multilokusová sekvenční typizace $7 D058885
- 651 _2
- $a Itálie $x epidemiologie $7 D007558
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Caltagirone, Maria Sofia $u Microbiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy
- 700 1_
- $a Mattioni Marchetti, Vittoria $u Scienze Clinico, Chirurgiche, Diagnostiche, Pediatriche Department, Microbiology Unit, University of Pavia, Pavia, Italy $u Specialization School of Microbiology and Virology, University of Pavia, Pavia, Italy
- 700 1_
- $a Rezzani, Antonella $u Microbiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy
- 700 1_
- $a Navarra, Antonella $u Microbiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy
- 700 1_
- $a Bitar, Ibrahim $u Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia $u Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czechia
- 773 0_
- $w MED00174364 $t Euro surveillance $x 1560-7917 $g Roč. 29, č. 21 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38785090 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134114 $b ABA008
- 999 __
- $a ok $b bmc $g 2143674 $s 1225890
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 29 $c 21 $e - $i 1560-7917 $m Euro surveillance $n Euro Surveill $x MED00174364
- LZP __
- $a Pubmed-20240725